This study examines the current and future applications of molecular imaging (MI) across the drug development value chain and highlights key developments that must occur for these approaches to increasingly improve the drug development process. Leveraging focused contrast agents and diverse imaging technology platforms, MI is being used to visualize effects at the subcellular, cellular, tissue, organ, or whole-body level. As this technology finds increased usage at all stages of drug development, its impact is becoming increasingly clear.
Content
In This Study
Situation Overview
What Is Molecular Imaging?
Key Applications of Molecular Imaging in the Drug Development Process
Use of Molecular Imaging in Clinical Trials
Current Applications of Molecular Imaging by Therapeutic Area
Table: Use of Molecular Imaging Technologies in Early Stage Drug Development
Table: Comparison of Molecular Imaging Technologies Used in Clinical Trials
Table: Current Applications of Molecular Imaging by Therapeutic Area
Data Storage and Analysis Concerns
Future Outlook
Discovery Research Outlook
Preclinical Outlook
Clinical Outlook
Vendor Outlook
The Market Landscape for Molecular Imaging Technologies
Figure: Market Opportunity for Molecular Imaging Technologies in Drug Development
Essential Guidance
Learn More
Related Research
Synopsis